Longwood Fund
Longwood creates and invests in science-based companies that develop novel solutions for important medical problems.
📥 Buy Full VC Dataset
Offices: Boston (United States)
Investment Stages: Series A, Series B
Markets: Healthcare, Biotech
Founded Year: 2010
Investor Type: Venture Capital
Portfolio Companies: Evommune, Weaver, Xaira, Progentos, Bbot, Engrail, Doppler, Solu, AAVantgarde, DEM, Carbon, Photys, Rectify, Interius, Xylocor, Be Bio, Immunitas Therapeutics, Pyxis Oncology, Lassen Therapeutics, Werewolf, TScan, Archer, Sitryx, Bicycle Therapeutics, Grail, Pulmocide, Axial Therapeutics, Millendo Therapeutics, Channel Medsystems, Kalvista Pharmaceuticals, Colorescience, Calithera Biosciences, Mitobridge, Illuminoss, Verastem, PTC Therapeutics, Alnara
Website: https://www.longwoodfund.com
Team Page: https://www.longwoodfund.com/people
Portfolio Link: https://www.longwoodfund.com/portfolio
LinkedIn: https://www.linkedin.com/company/longwoodfund
Twitter: https://twitter.com/LongwoodFund
Crunchbase: https://www.crunchbase.com/organization/longwood-founders-fund
Comments
No comments yet. Be the first to comment!